Clinical trial
Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)
NCT04765592 is registered in ClinicalTrials.gov with Hangzhou Endonom Medtech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)
- Lead sponsor
- Hangzhou Endonom Medtech Co., Ltd.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- June 7, 2021
- Completion date
- February 5, 2029
- Enrollment
- 88 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
aortic arch aneurysm